Lobbying Filing Details

Total Spending

$50,000

Activities

1

Lobbyists

1

Gov't Entities

2

Filing Information

Filing UUID:: a81daf4f-e156-4317-94c8-303340aca7a8
Type:: Q4 - 4th Quarter - Report
Period:: 2020 - 4th Quarter (Oct 1 - Dec 31)
Date Posted:: January 15, 2021 at 8:05 PM
Income:: $50,000
Expenses:: $0
Document URL:: View Submission

Quick Info

Document Type: text/html
Posted By: Nicole Carelli

Registrant

BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP

Law firm

Washington, District of Columbia

Client

CHIMERIX, INC.

Biopharmaceutical company.

North Carolina, United States of America

Lobbying Activities (1)

Activity 1

Health Issues

MCM development & procurement process; S. 1895, Lower Health Care Costs Act, provisions related to drug PRVs; H.R. 4439, Creating Hope Reauthorization Act; H.R. 133, FY2021 Omnibus and COVID Relief and Response Act, funding for Public Health and Social Services Emergency Fund.

Lobbyists (1)

NICOLE CARELLI

Government Entities (2)

SENATE
HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 5, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.